CORM-2 prevents human gingival fibroblasts from lipoteichoic acid-induced VCAM-1 and ICAM-1 expression by inhibiting TLR2/MyD88/TRAF6/PI3K/Akt/ROS/NF-κB signaling pathway

Biochem Pharmacol. 2022 Jul:201:115099. doi: 10.1016/j.bcp.2022.115099. Epub 2022 May 23.

Abstract

Periodontal diseases are prevalent worldwide. Lipoteichoic acid (LTA), a major component of gram-positive bacteria, may play a key role in periodontally inflammatory diseases. Carbon monoxide (CO) is a critical messenger in many biological processes. It can elicit various biological properties, especially anti-inflammatory effects. As the straight administration of CO remains difficult, CO-releasing molecules (CO-RMs) are emerging as promising alternatives. To explore the pharmacological actions and signaling pathways of CO battling LTA-induced periodontal inflammation, this study investigated the cytoprotective effects of CORM-2 against the adhesion of THP-1 monocytes to human gingival fibroblasts (HGFs) and the underlying molecular mechanism. After exposing HGFs to LTA with or without CORM-2 pretreatment, monocyte adhesion was determined. VCAM-1 and ICAM-1 expression in HGFs was measured by real-time PCR. To identify the signaling pathways of CO involved in the cytoprotective effects of CORM-2, HGFs underwent pharmacological or genetical interventions before LTA incubation. The expression and/or activity of possible regulatory molecules were determined. The release of pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, were measured using ELISA. The results showed that LTA increased cytokine production and upregulated VCAM-1 and ICAM-1 expression in HGFs, promoting monocyte adhesion. These events were dependent on TLR2/MyD88/TRAF6- and PI3K/Akt/NADPH oxidase/ROS-regulated NF-κB activation. CORM-2 inhibited LTA-induced inflammatory cascades in HGFs, in which CO seemed to be the hitman. To conclude, CO released from CORM-2 can prevent the LTA-stimulated HGFs from increasing VCAM-1 and ICAM-1 expression and promoting monocyte adhesion by inhibiting TLR2/MyD88/TRAF6 association and PI3K/Akt/NADPH oxidase/ROS signaling, both converge on the canonical NF-κB activation.

Keywords: Carbon monoxide; Carbon monoxide-releasing molecules; Lipoteichoic acid; Monocyte adhesion; Reactive oxygen species; Toll-like receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fibroblasts
  • Humans
  • Intercellular Adhesion Molecule-1 / genetics
  • Intercellular Adhesion Molecule-1 / metabolism
  • Lipopolysaccharides
  • Myeloid Differentiation Factor 88 / metabolism
  • NADPH Oxidases / metabolism
  • NF-kappa B* / metabolism
  • Organometallic Compounds* / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Reactive Oxygen Species* / metabolism
  • Signal Transduction
  • TNF Receptor-Associated Factor 6* / metabolism
  • Teichoic Acids
  • Toll-Like Receptor 2* / genetics
  • Toll-Like Receptor 2* / metabolism
  • Vascular Cell Adhesion Molecule-1* / genetics
  • Vascular Cell Adhesion Molecule-1* / metabolism

Substances

  • Lipopolysaccharides
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Organometallic Compounds
  • Reactive Oxygen Species
  • TLR2 protein, human
  • TNF Receptor-Associated Factor 6
  • Teichoic Acids
  • Toll-Like Receptor 2
  • Vascular Cell Adhesion Molecule-1
  • tricarbonyldichlororuthenium (II) dimer
  • Intercellular Adhesion Molecule-1
  • lipoteichoic acid
  • NADPH Oxidases
  • Proto-Oncogene Proteins c-akt